Managing Propranolol-Induced Dizziness

Introduction to Propranolol and Dizziness

• Propranolol is a non-selective beta-blocker used for various conditions, including ventricular arrhythmias, atrial fibrillation rate control, supraventricular tachycardia, and migraine prevention 1, 2, 3, 4, 5
• The American Heart Association identifies dizziness as a common adverse effect of propranolol, as noted in the 2017 AHA/ACC/HRS guideline 1
• The European Society of Cardiology also notes dizziness among reported adverse symptoms in the 2016 ESC guidelines for atrial fibrillation management 2, 3

Management Strategies

• The American College of Cardiology recommends reducing the dose of propranolol to the smallest effective dose to achieve rate control while minimizing side effects, as suggested in the European Heart Journal 3, 6
• The European Heart Journal suggests considering extended-release formulations of propranolol, which provide more stable plasma concentrations with fewer peak-related side effects 1
• Switching to a cardioselective beta-blocker, such as metoprolol, bisoprolol, or atenolol, may cause fewer side effects, as recommended by the European Heart Journal and the Journal of the American College of Cardiology 2, 3, 7, 8
• Dividing the daily dose of propranolol into smaller, more frequent doses can help avoid high peak concentrations, as suggested by the Journal of the American College of Cardiology 1, 9
• Taking propranolol with food may slow absorption and reduce peak-related side effects, although this is not explicitly cited in the provided references

Special Considerations

• Elderly patients are more susceptible to dizziness and should start with lower doses of propranolol, as recommended by the European Heart Journal 3
• Patients with renal impairment may require dose adjustment, as noted in the European Heart Journal 2
• Patients with hepatic impairment may require dose reduction, as propranolol is extensively metabolized by the liver, according to the European Heart Journal 6

Contraindications and Monitoring

• The American College of Cardiology recommends considering alternative treatments when dizziness persists despite dose adjustments, or when significant bradycardia or hypotension develops, as noted in the Journal of the American College of Cardiology 1, 2, 3, 4
• Contraindications for continuing propranolol include severe bradycardia or heart block, decompensated heart failure, cardiogenic shock, and severe hypotension, as recommended by the Journal of the American College of Cardiology 1, 7, 9
• Regular monitoring of blood pressure and heart rate is recommended, especially after dose adjustments, as suggested by the European Heart Journal and the Journal of the American College of Cardiology 1, 2